Literature DB >> 31782053

Circulating Wnt1-inducible signaling pathway protein-1 (WISP-1/CCN4) is a novel biomarker of adiposity in subjects with type 2 diabetes.

Vadim V Klimontov1, Dinara M Bulumbaeva1, Olga N Fazullina1, Alexander P Lykov1, Natalia P Bgatova1, Nikolay B Orlov1, Vladimir I Konenkov1, Andreas F H Pfeiffer2,3,4, Olga Pivovarova-Ramich5,6,7,8, Natalia Rudovich2,3,9.   

Abstract

BACKGROUND: Wnt1-inducible signaling pathway protein 1, or cellular communication network factor 4 (CCN4), a member of CCN family of secreted, extracellular matrix associated signaling proteins, recently was validated as a novel adipose tissue derived cytokine.
OBJECTIVE: To assess the relationships between circulating CCN4, adipose tissue distribution and function, and chronic low-grade inflammation in subjects with type 2 diabetes.
METHODS: We observed 156 patients with type 2 diabetes and 24 healthy controls. Serum levels of CCN4, hsCRP and alpha1-acid glycoprotein (alpha1-AGP) were measured by ELISA. Serum concentrations of leptin, resistin, visfatin, adipsin, adiponectin, IL-6, IL-8, IL-18 and TNF-alpha were determined by multiplex analysis. Fat mass and distribution was assessed by DEXA. Mean diameter of adipocytes was estimated in samples of subcutaneous adipose tissue.
RESULTS: Patients with diabetes had higher levels of circulating CCN4, leptin, resistin, adipsin, visfatin, hsCRP, alpha1-AGP, and IL-6 (all p < 0.02). The CCN4 concentration correlated positively with percentage of fat mass in central abdominal area, as well as with leptin, resistin and visfatin levels; negative correlation was found between CCN4 and mean adipocyte diameter. In multiple regression analysis fat mass in central abdominal area was independent predictor for CCN4 concentration.
CONCLUSION: In subjects with type 2 diabetes serum levels of CCN4 are associated with central abdominal fat mass and adipose tissue dysfunction.

Entities:  

Keywords:  Adipose tissue; Cytokines; Obesity; Type 2 diabetes; WISP-1/CCN4

Year:  2019        PMID: 31782053      PMCID: PMC7176766          DOI: 10.1007/s12079-019-00536-4

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  11 in total

Review 1.  Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancers.

Authors:  Andrew Leask
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-04       Impact factor: 4.249

2.  Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.

Authors:  Kenneth Maiese
Journal:  Int Rev Neurobiol       Date:  2020-08-11       Impact factor: 3.230

3.  Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity.

Authors:  Olga Pivovarova-Ramich; Jennifer Loske; Silke Hornemann; Mariya Markova; Nicole Seebeck; Anke Rosenthal; Frederick Klauschen; José Pedro Castro; René Buschow; Tilman Grune; Volker Lange; Natalia Rudovich; D Margriet Ouwens
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

Review 4.  New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2020-06-01

Review 5.  An Update to the WISP-1/CCN4 Role in Obesity, Insulin Resistance and Diabetes.

Authors:  Małgorzata Mirr; Maciej Owecki
Journal:  Medicina (Kaunas)       Date:  2021-01-23       Impact factor: 2.430

6.  Adipsin Serum Concentrations and Adipose Tissue Expression in People with Obesity and Type 2 Diabetes.

Authors:  Margarete Milek; Yusef Moulla; Matthias Kern; Christine Stroh; Arne Dietrich; Michael R Schön; Daniel Gärtner; Tobias Lohmann; Miriam Dressler; Peter Kovacs; Michael Stumvoll; Matthias Blüher; Esther Guiu-Jurado
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

7.  Factors associated with trabecular bone score in postmenopausal women with type 2 diabetes and normal bone mineral density.

Authors:  Olga N Fazullina; Anton I Korbut; Vadim V Klimontov
Journal:  World J Diabetes       Date:  2022-07-15

Review 8.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

9.  Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2020       Impact factor: 1.990

10.  Association Between Umbilical Cord Levels of Glypican-1, Glypican-3, Syndecan-1, WISP1, Leptin and Birth Weight of Small, Appropriate, and Large for Gestational Age Infants.

Authors:  Ayşe Anık; Özge Çevik; Sercan Öztürk; Ayça Tuzcu; Abdullah Barış Akcan; Emre Zafer; Münevver Kaynak Türkmen; Ahmet Anık
Journal:  Turk Arch Pediatr       Date:  2022-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.